Advertisement
News
Subscribe to MDT Magazine News

Ford Blue Oval Scholarships Available for San Antonio High School Students

March 15, 2011 6:38 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., SAN ANTONIO, Texas, March 14, 2011 — In partnership with Ford Motor Company Fund and Community Services, the SME Education Foundation announces the 2011 Ford Blue Oval Scholarship program for graduating high school seniors in Bexar County, Texas. As part of their...

OEMs, Suppliers Exploring Cutting-Edge Technologies for Composite Materials at AeroDef Manufacturing in April

March 15, 2011 5:33 am | by Society of Manufacturing Engineers | Comments

ANAHEIM, March 14, 2011 — The aerospace industry's unrelenting need to enhance the performance of commercial and military aircraft is constantly driving the development of improved high-performance structural materials. More

NewCardio to Conduct Corporate Update Conference Call on March 29, 2011

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., March 15, 2011 /- NewCardio, Inc. (OTC Bulletin Board: NWCI ), a cardiovascular diagnostic solutions developer, announced today that the Company expects to file its Form 10-K for the year ended December 31, 2010 on March 29, 2011 and management will conduct a...

TOPICS:
Advertisement

Matakina and PenRad Sign Letter of Intent to Display Volparaâ„¢ Volumetric Breast Density Results on Mammography Review Station

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

LAS VEGAS, March 15, 2011 /- Matakina International, Limited of New Zealand and PenRad Technologies, Inc., a leader in medical image and information management, today announced that the companies have signed a Letter of Intent (LOI) to use the PenRad Mammography Information System (MIS)...

TOPICS:

Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

WESTFORD, Mass., March 15, 2011 /- Cynosure, Inc. (Nasdaq: CYNO ), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that two of its newest workstations for laser-assisted lipolysis and non-invasive cellulite...

TOPICS:

Vystar® Corporation Secures a $3M Credit Facility to Fund Growth

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

ATLANTA, March 15, 2011 /- Vystar® Corporation (OTC Bulletin Board: VYST ), the creator of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw material that significantly reduces antigenic proteins found in natural rubber latex, has secured $3 million in debt...

TOPICS:

NAFE Names Lilly to Top 50 Companies for Executive Women

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, March 15, 2011 /- Eli Lilly and Company (NYSE: LLY ) has been named to the 2011 NAFE Top 50 Companies for Executive Women by the National Association for Female Executives (NAFE).  The list recognizes organizations whose policies and practices encourage women's...

TOPICS:

iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 15, 2011 /- iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that it has commenced patient recruitment in an open-label, proof-of-concept Phase 1b study of its lead compound ITX-5061 in...

TOPICS:
Advertisement

iTherX Appoints Stefan Zeuzem, M.D., as Chair of Scientific and Clinical Advisory Board

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 15, 2011 /- iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that Stefan Zeuzem, M.D., has joined the company as Chair of the Scientific and Clinical Advisory Board.  Dr. Zeuzem will...

TOPICS:

LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

CENTENNIAL, Colo. and ALISO VIEJO, Calif., March 15, 2011 /- LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry...

TOPICS:

Nottingham University Hospital is First U.K. User of Elekta's Electronic Medical Record Workspace for Image Guided Radiation Therapy

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

NOTTINGHAM, England, March 15, 2011 /- Delivering Image Guided Radiation Therapy (IGRT) effectively and safely involves careful coordination of sophisticated systems, such as the therapy machine and its imaging subsystems, as well as the electronic medical record (EMR) used to schedule...

TOPICS:

Oconee Medical Center is Winner of Siemens 'Who Inspires You?' Video Contest

March 15, 2011 5:32 am | by Bio-Medicine.Org | Comments

LAS VEGAS, March 15, 2011 /- Oconee Medical Center in Seneca, S.C., is the winner of Siemens "Who Inspires You?" video contest and the recipient of a new MAMMOMAT® Inspiration, Siemens next generation full-field digital mammography system. (Photo:...

TOPICS:

Repligen imaging agent meets goal in study review

March 15, 2011 4:45 am | by The Associated Press | Comments

Repligen Corp. said that its imaging agent RG1068 met its goals in a late stage clinical trial, as it allowed radiologists to accurately scan the pancreas of their patients without producing many more false positives.The results, disclosed Monday, come from a new analysis of the trial. Repligen...

510(k) Implementation: Discussion of an On-line Repository of Medical Device Labeling, and of Making Device Photographs Available in a Public Database Without Disclosing Propr...

March 15, 2011 4:37 am | by U.S. Food & Drug Administration | Comments

CDRH is exploring the development of a searchable medical device labeling repository that would be accessible by the public and provide useful product information to patients and health care practitioners. This might be similar to the labeling...

Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results

March 15, 2011 4:35 am | by Bio-Medicine.Org | Comments

SEATTLE, March 15, 2011 /- Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading